Growth Metrics

Conmed (CNMD) EBITDA Margin (2010 - 2026)

Conmed posted quarterly EBITDA Margin of 4.87% for Q1 2026, up 253.0% year-on-year from 1.38% in Q1 2025, and down 7.65% on a QoQ basis from 5.27% in Q4 2025.

Conmed (CNMD) has 17 years of EBITDA Margin data on file, last reported at 4.87% in Q1 2026.

  • For the quarter ending Q1 2026, EBITDA Margin rose 253.0% year-over-year to 4.87%; the trailing twelve-month figure through Mar 2026 stood at 4.93% (down 352.0% YoY), and the FY2025 full-year result was 4.34%, down 513.0% from the prior year.
  • EBITDA Margin for Q1 2026 stood at 4.87%, down from 5.27% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 15.68% in Q3 2022 and bottomed at 62.28% in Q2 2022.
  • The 5-year median for EBITDA Margin is 6.43% (2024), against an average of 3.2%.
  • The widest annual swing landed in 2022, when EBITDA Margin sank 6923 bps; it then soared 6724 bps in 2023.
  • A 5-year view of EBITDA Margin shows it stood at 11.5% in 2022, then slipped by 2 bps to 11.27% in 2023, then decreased by 24 bps to 8.56% in 2024, then slumped by 38 bps to 5.27% in 2025, then retreated by 8 bps to 4.87% in 2026.
  • The last three EBITDA Margin figures came in at 4.87% (Q1 2026), 5.27% (Q4 2025), and 1.95% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 12.05%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 15.55%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 16.24%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 14.52%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.04%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.94%
10 Conmed 1.06 Bn 1.02 Bn 183.45 Mn 4.87%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.87%
Dec 31, 2025 5.27%
Sep 30, 2025 1.95%
Jun 30, 2025 7.55%
Mar 31, 2025 2.33%
Dec 31, 2024 8.56%
Sep 30, 2024 15.38%
Jun 30, 2024 7.63%
Mar 31, 2024 6.43%
Dec 31, 2023 11.27%
Sep 30, 2023 4.87%
Jun 30, 2023 4.96%
Mar 31, 2023 1.59%
Dec 31, 2022 11.50%
Sep 30, 2022 15.68%
Jun 30, 2022 -62.28%
Mar 31, 2022 6.77%
Dec 31, 2021 10.87%
Sep 30, 2021 5.53%
Jun 30, 2021 6.95%
Mar 31, 2021 4.62%
Dec 31, 2020 8.69%
Sep 30, 2020 3.77%
Jun 30, 2020 -15.66%
Mar 31, 2020 -0.52%
Dec 31, 2019 5.12%
Sep 30, 2019 2.00%
Jun 30, 2019 2.41%
Mar 31, 2019 0.50%
Dec 31, 2018 5.07%
Sep 30, 2018 3.53%
Jun 30, 2018 3.43%
Mar 31, 2018 6.63%
Dec 31, 2017 20.34%
Sep 30, 2017 5.49%
Jun 30, 2017 5.15%
Mar 31, 2017 -0.50%
Dec 31, 2016 0.00%
Sep 30, 2016 4.28%
Jun 30, 2016 0.70%
Mar 31, 2016 0.43%
Dec 31, 2015 4.07%
Sep 30, 2015 2.21%
Jun 30, 2015 4.77%
Mar 31, 2015 -2.09%
Dec 31, 2014 -3.62%
Sep 30, 2014 -2.39%
Jun 30, 2014 6.16%
Mar 31, 2014 5.26%
Dec 31, 2013 9.64%
Sep 30, 2013 4.23%
Jun 30, 2013 3.82%
Mar 31, 2013 6.08%
Dec 31, 2012 5.13%
Sep 30, 2012 5.61%
Jun 30, 2012 4.05%
Mar 31, 2012 5.68%
Dec 31, 2011 -21.01%
Sep 30, 2011 3.72%
Jun 30, 2011 5.90%
Mar 31, 2011 6.55%
Dec 31, 2010 7.36%
Sep 30, 2010 8.83%
Jun 30, 2010 8.16%